Posted on

Reflection on Life 10 Years After Stem Cell Transplant

Loading

By Robert Trebor

A decade ago, I was diagnosed with acute myeloid leukemia and underwent aggressive chemotherapy and an allogenic stem cell transplant. Though I still have complications related to my cancer, I’m thankful for what I still have.

I’m still alive. This was not a given 10 years ago, when I was diagnosed with an aggressive case of acute myeloid leukemia (AML).

The usual chemo for AML was applied, but after a few weeks of remission I relapsed, confounding my oncologists. Read the full story in Cure Today.

Loading
Posted on

Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant

Loading

Front Oncol. 2022 Feb 25;12:801879. doi: 10.3389/fonc.2022.801879. eCollection 2022.

ABSTRACT

BACKGROUND: Allogeneic hematopoietic stem cell transplant (allo-HCT) is a potential curative therapy for a variety of hematologic disorders. However, it requires highly specialized care that is only available at select centers across the country. Thus, minority populations are at risk for healthcare disparities in access to and outcomes of allo-HCT. Our study aimed to assess the impact of race and location of residence on outcomes of allo-HCT. Read more.

Loading